vs
Side-by-side financial comparison of GRAIL, Inc. (GRAL) and NorthEast Community Bancorp, Inc. (NECB). Click either name above to swap in a different company.
GRAIL, Inc. is the larger business by last-quarter revenue ($43.6M vs $26.4M, roughly 1.6× NorthEast Community Bancorp, Inc.). NorthEast Community Bancorp, Inc. runs the higher net margin — 40.9% vs -227.5%, a 268.4% gap on every dollar of revenue. On growth, GRAIL, Inc. posted the faster year-over-year revenue change (14.0% vs 3.9%). NorthEast Community Bancorp, Inc. produced more free cash flow last quarter ($50.8M vs $-63.9M). Over the past eight quarters, GRAIL, Inc.'s revenue compounded faster (27.7% CAGR vs 1.8%).
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
NorthEast Community Bancorp, Inc. (MD) is a U.S.-based bank holding company operating primarily in the Mid-Atlantic region. It provides a comprehensive suite of consumer and commercial banking services, including deposit products, mortgage loans, small business financing, and wealth management solutions to individual and local enterprise clients.
GRAL vs NECB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $43.6M | $26.4M |
| Net Profit | $-99.2M | $10.8M |
| Gross Margin | — | — |
| Operating Margin | -285.4% | 59.0% |
| Net Margin | -227.5% | 40.9% |
| Revenue YoY | 14.0% | 3.9% |
| Net Profit YoY | -2.2% | 5.8% |
| EPS (diluted) | $-2.37 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.6M | $26.4M | ||
| Q3 25 | $36.2M | $27.0M | ||
| Q2 25 | $35.5M | $25.9M | ||
| Q1 25 | $31.8M | $25.5M | ||
| Q4 24 | $38.3M | $25.4M | ||
| Q3 24 | $28.7M | $27.6M | ||
| Q2 24 | $32.0M | $27.0M | ||
| Q1 24 | $26.7M | $25.5M |
| Q4 25 | $-99.2M | $10.8M | ||
| Q3 25 | $-89.0M | $11.9M | ||
| Q2 25 | $-114.0M | $11.2M | ||
| Q1 25 | $-106.2M | $10.6M | ||
| Q4 24 | $-97.1M | $10.2M | ||
| Q3 24 | $-125.7M | $12.7M | ||
| Q2 24 | $-1.6B | $12.8M | ||
| Q1 24 | $-218.9M | $11.4M |
| Q4 25 | -285.4% | 59.0% | ||
| Q3 25 | -346.2% | 61.6% | ||
| Q2 25 | -446.9% | 59.5% | ||
| Q1 25 | -482.5% | 57.4% | ||
| Q4 24 | -358.0% | 57.0% | ||
| Q3 24 | -640.5% | 63.6% | ||
| Q2 24 | -5133.8% | 65.6% | ||
| Q1 24 | -851.1% | 62.7% |
| Q4 25 | -227.5% | 40.9% | ||
| Q3 25 | -245.8% | 44.0% | ||
| Q2 25 | -320.7% | 43.1% | ||
| Q1 25 | -333.6% | 41.4% | ||
| Q4 24 | -253.8% | 40.1% | ||
| Q3 24 | -438.7% | 45.9% | ||
| Q2 24 | -4958.8% | 47.5% | ||
| Q1 24 | -819.3% | 44.5% |
| Q4 25 | $-2.37 | $0.78 | ||
| Q3 25 | $-2.46 | $0.87 | ||
| Q2 25 | $-3.18 | $0.82 | ||
| Q1 25 | $-3.10 | $0.78 | ||
| Q4 24 | $-1.49 | $0.74 | ||
| Q3 24 | $-3.94 | $0.95 | ||
| Q2 24 | $-51.06 | $0.97 | ||
| Q1 24 | $-7.05 | $0.86 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $249.7M | $81.2M |
| Total DebtLower is stronger | — | $70.0M |
| Stockholders' EquityBook value | $2.6B | $351.7M |
| Total Assets | $2.9B | $2.1B |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $249.7M | $81.2M | ||
| Q3 25 | $126.9M | $64.3M | ||
| Q2 25 | $127.4M | $59.4M | ||
| Q1 25 | $133.9M | $89.5M | ||
| Q4 24 | $214.2M | $78.3M | ||
| Q3 24 | $853.6M | $97.8M | ||
| Q2 24 | $958.8M | $113.9M | ||
| Q1 24 | $199.7M | $107.4M |
| Q4 25 | — | $70.0M | ||
| Q3 25 | — | $170.0M | ||
| Q2 25 | — | $135.0M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $47.0M | ||
| Q1 24 | — | $47.0M |
| Q4 25 | $2.6B | $351.7M | ||
| Q3 25 | $2.2B | $344.0M | ||
| Q2 25 | $2.3B | $336.7M | ||
| Q1 25 | $2.4B | $327.2M | ||
| Q4 24 | $2.5B | $318.3M | ||
| Q3 24 | $2.6B | $309.6M | ||
| Q2 24 | $2.7B | $300.0M | ||
| Q1 24 | — | $288.9M |
| Q4 25 | $2.9B | $2.1B | ||
| Q3 25 | $2.6B | $2.1B | ||
| Q2 25 | $2.7B | $2.0B | ||
| Q1 25 | $2.8B | $1.9B | ||
| Q4 24 | $3.0B | $2.0B | ||
| Q3 24 | $3.1B | $2.0B | ||
| Q2 24 | $3.3B | $1.9B | ||
| Q1 24 | — | $1.9B |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.49× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 0.16× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-63.8M | $52.6M |
| Free Cash FlowOCF − Capex | $-63.9M | $50.8M |
| FCF MarginFCF / Revenue | -146.5% | 192.3% |
| Capex IntensityCapex / Revenue | 0.2% | 6.6% |
| Cash ConversionOCF / Net Profit | — | 4.86× |
| TTM Free Cash FlowTrailing 4 quarters | $-299.9M | $89.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-63.8M | $52.6M | ||
| Q3 25 | $-63.2M | $14.1M | ||
| Q2 25 | $-77.0M | $15.6M | ||
| Q1 25 | $-95.0M | $10.9M | ||
| Q4 24 | — | $48.7M | ||
| Q3 24 | $-104.6M | $14.4M | ||
| Q2 24 | $-171.8M | $11.1M | ||
| Q1 24 | $-207.3M | $12.9M |
| Q4 25 | $-63.9M | $50.8M | ||
| Q3 25 | $-63.6M | $13.6M | ||
| Q2 25 | $-77.3M | $14.9M | ||
| Q1 25 | $-95.1M | $10.6M | ||
| Q4 24 | — | $48.2M | ||
| Q3 24 | $-105.6M | $14.2M | ||
| Q2 24 | $-173.2M | $11.0M | ||
| Q1 24 | $-209.8M | $12.8M |
| Q4 25 | -146.5% | 192.3% | ||
| Q3 25 | -175.8% | 50.5% | ||
| Q2 25 | -217.6% | 57.3% | ||
| Q1 25 | -298.6% | 41.4% | ||
| Q4 24 | — | 189.3% | ||
| Q3 24 | -368.4% | 51.5% | ||
| Q2 24 | -541.7% | 40.8% | ||
| Q1 24 | -785.3% | 50.3% |
| Q4 25 | 0.2% | 6.6% | ||
| Q3 25 | 1.1% | 1.6% | ||
| Q2 25 | 1.0% | 2.9% | ||
| Q1 25 | 0.2% | 1.5% | ||
| Q4 24 | — | 2.0% | ||
| Q3 24 | 3.4% | 0.6% | ||
| Q2 24 | 4.3% | 0.5% | ||
| Q1 24 | 9.5% | 0.3% |
| Q4 25 | — | 4.86× | ||
| Q3 25 | — | 1.18× | ||
| Q2 25 | — | 1.40× | ||
| Q1 25 | — | 1.04× | ||
| Q4 24 | — | 4.77× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 0.87× | ||
| Q1 24 | — | 1.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GRAL
| Screening Revenue | $42.3M | 97% |
| Developmental Services Revenue | $1.3M | 3% |
NECB
Segment breakdown not available.
